PARP1 and neoplasm: In this study, the induction of PD-L1 expression was observed in only two tumor models (SK6005 and SA9003) (data not shown) but not in the rest of the tumor models examined, suggesting that the elevation of PD-L1 expression by PARP inhibitors could be context-dependent.